Attentional Bias Retraining in Veterans (ABR)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Aim 1: Develop Attentional Bias Retraining protocol (Phase 1)
- 1.1 Computerized assessment & retraining programs
- 1.2 Procedures and measures
Aim 2: Implement in pilot sample (Phase 2)
- 2.1: Assess feasibility and tolerability
- 2.2: Collect pilot data to plan future studies
- 2.3: Efficacy estimates based on changes in response time to dot probe task
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Hawaii
-
Honolulu, Hawaii, United States, 96819
- National Center for PTSD
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Participated in ground combat operations in Vietnam
- Scored 40 - 80 on PTSD Checklist - Military version
- Availability and willingness to attend 2x weekly computer sessions for 6 weeks
Exclusion Criteria:
- Active substance dependence
- Significant cognitive impairment
- Current and active suicidal or homicidal ideation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
OTHER: Attentional Bias Retraining
Each participant receives 12 sessions.
The first three sessions are baseline (assessment only) sessions.
The last four sessions must be treatment sessions.
The attentional bias intervention starts randomly on sessions 4 - 8, and continues until the end of the 12 sessions.
|
Participants complete a computer-based intervention, which is designed to correct cognitive biases associated with PTSD by training to attend to neutral information rather than the trauma-related cue words.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Post-traumatic Checklist - Military version (PCL-M)
Time Frame: Change from Baseline and Post-treatment (1 month after last training session)
|
PCL-M assess the 17-cardinal symptoms of PTSD.
|
Change from Baseline and Post-treatment (1 month after last training session)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Attentional bias scores
Time Frame: Change from Baseline and Post-treatment (1 month after last training session)
|
Attentional bias scores represent participants cognitive bias to orient towards trauma-relevant information more quickly than neutral information.
|
Change from Baseline and Post-treatment (1 month after last training session)
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Daily of PTSD symptoms, specifically hyperarousal and intrusive symptoms (nightmares, reenactments, and triggered and untriggered recall)
Time Frame: Change from Baseline and Post-treatment (1 month after last training session)
|
Participants filled out daily symptom log nightly
|
Change from Baseline and Post-treatment (1 month after last training session)
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Margaret-Anne Mackintosh, PhD, National Center for PTSD/PHREI
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2012-05/MM/PROMISE 0001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.